SBIR/STTR Phase II: Thermostable Phage DNA Polymerases: Improved Tools for Genomics Research

Award Information
Agency:
National Science Foundation
Branch
n/a
Amount:
$0.00
Award Year:
2002
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Award Id:
58276
Agency Tracking Number:
0215988
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Lucigen Corporation (formerly Microgen - a WI Corp) (Currently LUCIGEN CORPORATION)
2120 Greenview Dr., Middleton, WI, 53562
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Thomas Schoenfeld
(608) 831-9012
tschoenfeld@microgen.org
Business Contact:
() -
Research Institution:
n/a
Abstract
This Small Business Innovation Research Phase II project will develop novel DNA polymerase reagents for use in current and developing DNA diagnostic procedures. The approach is to develop thermophilic phage DNA replicases in place of the currently used DNA repair enzymes. The feasibility of this approach was demonstrated during Phase I research. This follow on Phase II project will extend the methods used in Phase I to isolate additional activities, characterize them and develop them as reagents for various amplification platforms. The commercial applications of this project will be in a number of markets that use molecular analysis of DNA. They include the areas of biomedical research, medical testing, genetic identity testing, public health and agriculture.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government